Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Blood Cells Mol Dis. 2012 Nov 11;50(2):99–104. doi: 10.1016/j.bcmd.2012.10.006

Figure 4. Monitoring for hepatic and renal toxicity.

Figure 4

Median and range of alanine aminotransferase (a) and creatinine (b) at baseline and during study. The trend line connects the medians. Each time-point represents between 13-22 observations.